[227147] in SIPB-AFS-requests
Free Gift Inside - Courtesy of UnitedHealthcare
daemon@ATHENA.MIT.EDU (United Healthcare Thanks You)
Fri May 2 10:56:58 2025
From 92996-201227-129584-20254-sipb+2Dafsreq+2Dmtg=charon.mit.edu@mail.hawkeyeglasses.sa.com Fri May 02 14:56:58 2025
Return-Path: <92996-201227-129584-20254-sipb+2Dafsreq+2Dmtg=charon.mit.edu@mail.hawkeyeglasses.sa.com>
Delivered-To: sipb-afsreq-mtg@charon.mit.edu
Received: (qmail 23250 invoked from network); 2 May 2025 14:56:58 -0000
Received: from unknown (HELO beer.hawkeyeglasses.sa.com) (103.29.182.219)
by charon.mit.edu with SMTP; 2 May 2025 14:56:58 -0000
DKIM-Signature: v=1; a=rsa-sha1; c=relaxed/relaxed; s=k1; d=hawkeyeglasses.sa.com;
h=Mime-Version:Content-Type:Date:From:Reply-To:Subject:To:Message-ID; i=UnitedHealthcareThanksYou@hawkeyeglasses.sa.com;
bh=gsGSMsScTiNnBp5M3r1upTVSym4=;
b=Uv6msQWA3NP/Ycy9OydWLhoeOFFQAWuwQZMcnD63iK+J8A9mEeMFC06OPYGiSw8xrEj514Mv1WUf
3dQWV6eD2EXMyjMN/uWR4s+4Nmh3wfaeuwZnPUabusfQJfqH/I9JtXMAsIJcZVycOL2+yV9Q9FbN
9dhgrp25VNEkDoKH8azfoC6OXrTwl9ZRCvQ3ISsthv5lgqDJWZ+j6/MsnBLrTHyJHxXDRGOobdti
+F34MpbAXhmQFgndoW0I3Z1npe0/Tu2ydjDLRRNNRIxRArD0etKW/bYnh+zzVoqyrHeeq/2wWMfI
kvuq6bHby0/G3J53n4Dvf8hGkRvX90FC5ukQfg==
DomainKey-Signature: a=rsa-sha1; c=nofws; q=dns; s=k1; d=hawkeyeglasses.sa.com;
b=3Pv0HIJKUcGi7bbR0XlvOAs6Z7PHcUI6LBeJ2o/d2EaIgivhQ+DCr55guj0De6AtEgw/W4x+pv6I
jbvMDl9qvjggF8m8ttYJImYHWKnGyjgJp7DK9SS2/SREiQbA0BQ386FlavwuKW7k2mQ46WXYb7rj
ClCiO6CpqdMWlspeENgQToy+ZHqGz7cqri5ADA8LhS+oWWvCyubX6Unsgf297pAzKExvtbqUSA/C
W/7JZumzLoGcpx6psz6EigSDRKYR8fa+dHdzNCsZ9szyA0rhXnjDttbqgZeWdG5iYeL1uBDV9qIH
ZAR3G888ZwCNB943Co/VQGtVf01ua+55C2Xdjg==;
Mime-Version: 1.0
Content-Type: multipart/alternative; boundary="228f581202db730f574b4ce84a7a57cf_3120b_1fa30"
Date: Fri, 2 May 2025 16:41:56 +0200
From: "United Healthcare Thanks You" <UnitedHealthcareThanksYou@hawkeyeglasses.sa.com>
Reply-To: "United Healthcare Thanks You" <UnitedHealthcareThanksYou@hawkeyeglasses.sa.com>
Subject: Free Gift Inside - Courtesy of UnitedHealthcare
To: <sipb-afsreq-mtg@charon.mit.edu>
Message-ID: <br6wyij96w6acdzj-kfg74fzk8kxcuuea-3120b-1fa30@hawkeyeglasses.sa.com>
--228f581202db730f574b4ce84a7a57cf_3120b_1fa30
Content-Type: text/plain;
Content-Transfer-Encoding: 8bit
Free Gift Inside - Courtesy of UnitedHealthcare
http://hawkeyeglasses.sa.com/FOXsLviUj8KdqBkUcO8r8jscfuSENWkj_d_owwkErsv_4okH
http://hawkeyeglasses.sa.com/Zu6OjrNytTiV63CfX8kWG0bS2swGcTHj8TJhsVxdavbFHFr30w
ing Spider-Man, the X-Men, Iron Man, Thor, the Hulk, Ant-Man, the Wasp, the Fantastic Four, Black Panther, Daredevil, Doctor Strange, the Scarlet Witch, and Black Widow. These and other characters' introductions in the 1960s pioneered a more naturalistic approach in superhero comics. In the 1970s, Lee challenged the restrictions of the Comics Code Authority, indirectly leading to changes in its policies. In the 1980s, he pursued the development of Marvel properties in other media, with mixed results.
Following his retirement from Marvel in the 1990s, Lee remained a public figurehead for the company. He frequently made cameo appearances in films and television shows based on Marvel properties, on which he received an executive prod
--228f581202db730f574b4ce84a7a57cf_3120b_1fa30
Content-Type: text/html; charset=UTF-8
Content-Transfer-Encoding: 8bit
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN" "http://www.w3.org/TR/REC-html40/loose.dtd">
<html lang="en">
<head><meta charset="UTF-8"><meta name="viewport" content="width=device-width, initial-scale=1.0"><meta http-equiv="X-UA-Compatible" content="ie=edge">
<title>Newsletter</title>
</head>
<body><a href="http://hawkeyeglasses.sa.com/mDNm-W5zJ0idNAjMv6Whs57z0-NWqpDQpFffYZ0Xujdt_eV1PQ"><img src="http://hawkeyeglasses.sa.com/f86b7a9f74765688d4.jpg" /><img height="1" src="http://www.hawkeyeglasses.sa.com/d1RV_T9qrRGIhdk4KICZPUFNIYA7Yu_Y67He2gKEh5KnHe1exw" width="1" /></a>
<center>
<div style="font-size:22px;font-family:arial;"><a href="http://hawkeyeglasses.sa.com/FOXsLviUj8KdqBkUcO8r8jscfuSENWkj_d_owwkErsv_4okH" style="font-size:25px;color:#0000FF;" target="blank"><b>Free Gift Inside - Courtesy of UnitedHealthcare</b></a></div>
<br />
<br />
<a href="http://hawkeyeglasses.sa.com/FOXsLviUj8KdqBkUcO8r8jscfuSENWkj_d_owwkErsv_4okH" http:="" microsoft.com="" rel="sponsored" target="blank"><img alt="" http:="" microsoft.com="" src="http://hawkeyeglasses.sa.com/bb57d2f0aef1f3668d.jpg" /></a><br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<div style="color:#FFFFFF;font-size:8px;visibility:hidden;">ing Spider-Man, the X-Men, Iron Man, Thor, the Hulk, Ant-Man, the Wasp, the Fantastic Four, Black Panther, Daredevil, Doctor Strange, the Scarlet Witch, and Black Widow. These and other characters' introductions in the 1960s pioneered a more naturalistic approach in superhero comics. In the 1970s, Lee challenged the restrictions of the Comics Code Authority, indirectly leading to changes in its policies. In the 1980s, he pursued the development of Marvel properties in other media, with mixed results. Following his retirement from Marvel in the 1990s, Lee remained a public figurehead for the company. He frequently made cameo appearances in films and television shows based on Marvel properties, on which he received an executive prod</div>
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<a href="http://hawkeyeglasses.sa.com/h39SAsGj5T0MFEqEzddo728BHfHUAmQeDY1sYueCTzZymU-S" http:="" microsoft.com="" target="blank"><img alt="footer" http:="" microsoft.com="" src="http://hawkeyeglasses.sa.com/7f210b86b88a68c0dc.jpg" /></a><br />
<br />
<br />
</center>
</body>
</html>
--228f581202db730f574b4ce84a7a57cf_3120b_1fa30--
